These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20420633)

  • 21. Management of combined hepatocellular and cholangiocarcinoma.
    Kassahun WT; Hauss J
    Int J Clin Pract; 2008 Aug; 62(8):1271-8. PubMed ID: 18284443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma.
    Groeschl RT; Turaga KK; Gamblin TC
    J Surg Oncol; 2013 May; 107(6):608-12. PubMed ID: 23386397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of combined hepatocelluar-cholangiocarcinoma and comparison with intrahepatic cholangiocarcinoma.
    Kim SH; Park YN; Lim JH; Choi GH; Choi JS; Kim KS
    Eur J Surg Oncol; 2014 Aug; 40(8):976-81. PubMed ID: 24909336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Dominant Component and Clinicopathological Characteristics of Combined Hepatocellular-cholangiocarcinoma After Radical Resection.
    Matsubara K; Kobayashi T; Tadokoro T; Namba Y; Fukuhara S; Oshita KO; Honmyo N; Kuroda S; Arihiro K; Ohdan H
    Anticancer Res; 2024 Oct; 44(10):4551-4559. PubMed ID: 39348996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated nomograms to predict overall survival and recurrence-free survival in patients with combined hepatocellular cholangiocarcinoma (cHCC) after liver resection.
    Wang T; Yang X; Tang H; Kong J; Shen S; Qiu H; Wang W
    Aging (Albany NY); 2020 Aug; 12(15):15334-15358. PubMed ID: 32788423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological factors impact the survival outcome following the resection of combined hepatocellular carcinoma and cholangiocarcinoma.
    Yap AQ; Chen CL; Yong CC; Kuo FY; Wang SH; Lin CC; Liu YW; Lin TL; Li WF; Millan CA; Wang CC
    Surg Oncol; 2013 Mar; 22(1):55-60. PubMed ID: 23102615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.
    Na SK; Choi GH; Lee HC; Shin YM; An J; Lee D; Shim JH; Kim KM; Lim YS; Chung YH; Lee YS
    PLoS One; 2018; 13(6):e0198138. PubMed ID: 29879137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumors with intrahepatic bile duct differentiation in cirrhosis: implications on outcomes after liver transplantation.
    Facciuto ME; Singh MK; Lubezky N; Selim MA; Robinson D; Kim-Schluger L; Florman S; Ward SC; Thung SN; Fiel M; Schiano TD
    Transplantation; 2015 Jan; 99(1):151-7. PubMed ID: 25029385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver transplantation for hepatic tumors: a systematic review.
    Ravaioli M; Ercolani G; Neri F; Cescon M; Stacchini G; Del Gaudio M; Cucchetti A; Pinna AD
    World J Gastroenterol; 2014 May; 20(18):5345-52. PubMed ID: 24833864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-invasive imaging in the diagnosis of combined hepatocellular carcinoma and cholangiocarcinoma.
    Shen YT; Yue WW; Xu HX
    Abdom Radiol (NY); 2023 Jun; 48(6):2019-2037. PubMed ID: 36961531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mixed hepatocellular and cholangiocarcinoma: a rare tumor with a mix of parent phenotypic characteristics.
    Bergquist JR; Groeschl RT; Ivanics T; Shubert CR; Habermann EB; Kendrick ML; Farnell MB; Nagorney DM; Truty MJ; Smoot RL
    HPB (Oxford); 2016 Nov; 18(11):886-892. PubMed ID: 27546172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver transplantation for intrahepatic cholangiocarcinoma.
    Lee DD; Croome KP; Musto KR; Melendez J; Tranesh G; Nakhleh R; Taner CB; Nguyen JH; Patel T; Harnois DM
    Liver Transpl; 2018 May; 24(5):634-644. PubMed ID: 29514406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Lee WS; Lee KW; Heo JS; Kim SJ; Choi SH; Kim YI; Joh JW
    Surg Today; 2006; 36(10):892-7. PubMed ID: 16998683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical features and outcomes of combined hepatocellular carcinoma and cholangiocarcinoma versus hepatocellular carcinoma versus cholangiocarcinoma after surgical resection: a propensity score matching analysis.
    Lin CW; Wu TC; Lin HY; Hung CM; Hsieh PM; Yeh JH; Hsiao P; Huang YL; Li YC; Wang YC; Shu CW; Chen YS
    BMC Gastroenterol; 2021 Jan; 21(1):20. PubMed ID: 33413162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response evaluation of locoregional therapies in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma versus hepatocellular carcinoma: a propensity score matched study.
    Mukund A; V Srinivasan S; Rana S; Vijayaraghavan R; Patidar Y; Arora V; Jindal A; Choudhury A; Shasthry SM; Sarin SK
    Clin Radiol; 2022 Feb; 77(2):121-129. PubMed ID: 34789395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular-cholangiocarcinoma.
    Chiu TJ; Chen YJ; Kuo FY; Chen YY
    PLoS One; 2020; 15(12):e0240791. PubMed ID: 33306714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Imaging and Clinically Relevant Features of Combined Hepatocellular Carcinoma and Cholangiocarcinoma with Hepatocellular Carcinoma.
    Huang X; Li Y; Long L
    Med Sci Monit; 2019 Nov; 25():8595-8601. PubMed ID: 31726461
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features.
    Maeda T; Adachi E; Kajiyama K; Sugimachi K; Tsuneyoshi M
    Hum Pathol; 1995 Sep; 26(9):956-64. PubMed ID: 7545644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging features of combined hepatocellular and cholangiocarcinoma compared with those of hepatocellular carcinoma and intrahepatic cholangiocellular carcinoma in a Chinese population.
    Wang Y; Yang Q; Li S; Luo R; Mao S; Shen J
    Clin Radiol; 2019 May; 74(5):407.e1-407.e10. PubMed ID: 30799097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor.
    Garancini M; Goffredo P; Pagni F; Romano F; Roman S; Sosa JA; Giardini V
    Liver Transpl; 2014 Aug; 20(8):952-9. PubMed ID: 24777610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.